Dynex is a Canadian venture capital firm which invests in biotechnology.
The investment focus is on projects in biological science and engineering. Our typical fund size ranges from $5M to $15M.
The Dynex GP is in harvest mode. The company manages a single fund in a single investment. The investment is in a revolutionary diagnostic platform with product licensed to several companies that dominate their national markets. We expect to monetize this maturing opportunity in 2015.